Transcat, Inc. TRNS

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Transcat’s 21.9% return over the past six months has outpaced the S&P 500 by 5.7%, and its stock price has climbed to $88.69 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Even if they go mostly unnoticed, industrial businesses are the backbone of our country. But they are at the whim of volatile macroeconomic factors that influence capital spending (like interest rates), and the industry has underperformed the market over the past six months as its 5% return lagged the S&P 500 by 8.3 percentage points.

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

ROCHESTER, N.Y., August 31, 2026--Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical

ROCHESTER, N.Y., August 27, 2026--Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September

Transcat’s second quarter saw the company exceed Wall Street’s revenue and non-GAAP profit expectations, powered by double-digit gains in both its Service and Distribution segments. Management pointed to particularly strong performance in regulated end markets such as life sciences, aerospace, and energy, where Transcat’s calibration business continues to gain market share. CEO Jaime Irick highlighted operational improvements and integration of recent acquisitions as key to the quarter’s growth,

Moby summary of Transcat, Inc.'s Q1 2027 earnings call

Transcat Inc (TRNS) reports 22% revenue growth in Q1 2027, with service revenue up 27% and management confident in achieving high single-digit organic growth for the fiscal year.

Measurement equipment distributor Transcat (NASDAQ:TRNS) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 21.6% year on year to $92.95 million. Its non-GAAP profit of $0.51 per share was 35.1% above analysts’ consensus estimates.

ROCHESTER, N.Y., August 04, 2026--Transcat Reports Strong Fiscal First Quarter 2027 Results with Double-Digit Service Organic Revenue Growth and Service Gross Margin Expansion

Measurement equipment distributor Transcat (NASDAQ:TRNS) will be announcing earnings results this Tuesday afternoon. Here’s what to expect.

Transcat has had an impressive run over the past six months as its shares have beaten the S&P 500 by 25.9%. The stock now trades at $86.15, marking a 34.3% gain. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.